Bruker 8-K
Leadership change
Falko Busse will step down as Bruker BioSpin President around May 1 and leave October 31, 2026, forfeiting unvested equity.
Filed 2026-04-10 16:02 ET
- 5.02 Officer/director change
Summary
Executive departure. Falko Busse, President of Bruker BioSpin and a Bruker executive officer, will transition out of those duties on or around 5/1/2026 and leave the company on 10/31/2026.
Key Figures
- Separation benefits: ≈$1.02M in severance, prorated bonus and unused-vacation payout, payable on 10/31/2026. Unvested equity awards held on that date will be forfeited.
The summary is written by an AI model reading the filing.
Model 005 · prompt 01d34d48e3